Can a dialysis-like treatment save kids with lung failure after transplant?

NCT ID NCT00120575

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether early hemofiltration, a continuous dialysis procedure, could improve survival in children who develop respiratory failure after a bone marrow transplant. Only 6 children took part. The idea was to filter out inflammatory molecules that drive lung damage. The trial is complete, but results are limited due to the very small number of participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
hemofiltration (a continuous form of dialysis)
What this could lead to
If it works, this could point toward a way to reduce deadly inflammation and improve survival in children with respiratory failure after bone marrow transplant.
What could go wrong
This was a very small, early-phase trial with only 6 participants, so results may not apply broadly. Hemofiltration carries risks like infection or bleeding, and the treatment may not change outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY DISTRESS SYNDROME are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Children's Healthcare of Atlanta @ Egleston

    Atlanta, Georgia, 30322, United States

  • Children's Hospital and Research Center

    Oakland, California, 94609, United States

  • Children's Hospital of British Columbia

    Vancouver, British Columbia, Canada

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

  • Duke University

    Durham, North Carolina, 27710, United States

  • Great Ormond Street Hospital

    London, United Kingdom

  • University of Ulm

    Ulm, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.